CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands		3 Months Ended
		Mar. 31, 2023	Mar. 31, 2022
TOTAL REVENUE		$ 9,588	$ 16,085
COST OF GOODS SOLD	[1]	(3,085)	(6,034)
RESEARCH AND DEVELOPMENT EXPENSES	[2]	(5,847)	(8,767)
SELLING, GENERAL AND ADMINISTRATIVE EXPENSES	[3]	(3,115)	(3,154)
OPERATING LOSS		(2,459)	(1,870)
FINANCIAL EXPENSES		(649)	(618)
FINANCIAL INCOME		172	202
FINANCIAL EXPENSES, NET		(477)	(416)
LOSS BEFORE TAXES ON INCOME		(2,936)	(2,286)
TAXES ON INCOME		(195)
NET LOSS FOR THE PERIOD		$ (3,131)	$ (2,286)
LOSS PER SHARE OF COMMON STOCK - BASIC		$ (0.05)	$ (0.05)
LOSS PER SHARE OF COMMON STOCK - DILUTED		$ (0.05)	$ (0.05)
WEIGHTED AVERAGE NUMBER OF SHARES OF COMMON STOCK USED IN COMPUTING LOSS PER SHARE - BASIC		57,480,009	45,843,563
WEIGHTED AVERAGE NUMBER OF SHARES OF COMMON STOCK USED IN COMPUTING LOSS PER SHARE - DILUTED		57,480,009	45,843,563
Goods
TOTAL REVENUE		$ 5,066	$ 9,028
License and R&D Services
TOTAL REVENUE		$ 4,522	$ 7,057

[1] (1) Includes share-based compensation

[2] (2) Includes share-based compensation

[3] (3) Includes share-based compensation